Prelude Therapeutics Inc

NASDAQ:PRLD   10:34:26 AM EDT
19.97
+1.97 (+10.94%)
Earnings Announcements

Prelude Therapeutics Announces Fourth Quarter And Full Year 2020 Financial Results And Provides Operational Update

Published: 03/16/2021 13:13 GMT
Prelude Therapeutics Inc (PRLD) - Prelude Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Update.
Q4 Loss per Share $0.45.
Q4 Earnings per Share Estimate $-0.49 -- Refinitiv Ibes Data (analyst estimates).
Current Cash & Cash Equivalents Will Be Sufficient to Fund Operating Expenses & Capital Expenditure Requirements Into 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.